Neoadjuvant immunotherapy facilitates surgery and improves outcomes for patients with high-risk liver cancer: Study Dr. Kamal Kant Kohli6 Sept 2024 8:30 PM ISTPatients with liver cancer who received immune checkpoint inhibitors (ICIs) before surgery-including those who would not have been eligible for...
Neoadjuvant immunotherapy confers therapeutic advantages in Head and Neck Cancer: JAMA Dr Ishan Kataria9 Sept 2021 9:00 AM ISTThe current standard of care for patients with locoregionally advanced head and neck squamous cell carcinoma (HNSCC) includes surgical resection...
Neoadjuvant therapy: An advancement in management of high-risk prostate cancer Dr. Nandita Mohan26 Nov 2020 4:00 PM ISTAccording to recent research, researchers have found out that neoadjuvant therapies maybe promising additions to the multimodal therapeutic...
